We are live on ! Find out more
NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

44 hedge funds and large institutions have $4.74M invested in NeuBase Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

2% more funds holding

Funds holding: 43 → 44 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

55% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 11

65% less capital invested

Capital invested by funds: $13.4M → $4.74M (-$8.64M)

Holders
44
Holders Change
+1
Holders Change %
+2.33%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
5
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CM
CM Management
Florida
+$66.2K
2
Renaissance Technologies
Renaissance Technologies
New York
+$39.9K
3
TSS
Two Sigma Securities
New York
+$26.5K
4
Citadel Advisors
Citadel Advisors
Florida
+$18.9K
5
Millennium Management
Millennium Management
New York
+$18.4K

Top Sellers

1
SCM
Sio Capital Management
New York
-$535K
2
ACM
AIGH Capital Management
Maryland
-$129K
3
Deutsche Bank
Deutsche Bank
Germany
-$105K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$39.6K
5
WVP
Worth Venture Partners
New Jersey
-$36.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$9K +$18.4K +1,115 New
Citadel Advisors
27
Citadel Advisors
Florida
$9K +$18.9K +1,140 New
KAM
28
Knightsbridge Asset Management
California
$8K -$1.75K -106 -9%
Bank of America
29
Bank of America
North Carolina
$6K – – –
OC
30
Oppenheimer & Co
New York
$6K – – –
WP
31
WealthSource Partners
California
$6K – – –
Jane Street
32
Jane Street
New York
$6K +$11.7K +708 New
Mariner
33
Mariner
Kansas
$6K +$12.8K +775 New
First Manhattan
34
First Manhattan
New York
$5K – – –
TRCT
35
Tower Research Capital (TRC)
New York
$5K +$9.02K +545 +556%
HWA
36
Heritage Wealth Advisors
Virginia
$3.95K – – –
Deutsche Bank
37
Deutsche Bank
Germany
– -$105K -5,000 Closed
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
– -$39.6K -2,396 -99%
UBS Group
39
UBS Group
Switzerland
– -$3K -123 Closed
CSS
40
Cubist Systematic Strategies
Connecticut
– -$2K -92 Closed
VVP
41
Venture Visionary Partners
Ohio
– -$698 -33 Closed
Morgan Stanley
42
Morgan Stanley
New York
– -$66 -4 -33%
JP Morgan Chase
43
JP Morgan Chase
New York
– +$17 +1 New
Simplex Trading
44
Simplex Trading
Illinois
– +$149 +9 New
Wells Fargo
45
Wells Fargo
California
– +$844 +51 +510%
1
2

NBSE Hedge Fund Activity: Q3 2022 in Review

44 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q3 2022, worth a combined $4.74M — down 65% from $13.4M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new NBSE positions and 6 closed out — a net gain of 1 holder — while 5 added to existing stakes and 11 trimmed.

The largest buyer was CM Management, adding an estimated $66.2K. The largest seller was Sio Capital Management, cutting an estimated $535K.

  • 44 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q3 2022, up from 43 in Q2 2022.
  • Funds reported $4.74M of NeuBase Therapeutics, Inc. Common Stock stock for Q3 2022, down 65% quarter-over-quarter.
  • 7 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q3 2022 and 6 closed out, a net change of +1 holder.
  • The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q3 2022 was CM Management, an estimated $66.2K added.
  • The largest NeuBase Therapeutics, Inc. Common Stock seller in Q3 2022 was Sio Capital Management, an estimated $535K sold.

Based on aggregated 13F filings for Q3 2022.